During a live event, Patrick Moore, MD, discussed the KarMMa-3 subgroup analyses and quality of life for patients with ...

The New England Journal of Medicine published results from the HERCULES phase 3 study demonstrating that tolebrutinib delayed disability ...

Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosisResults from the HERCULES phase 3 ...

LDC portfolio company RDi has completed the acquisition of Inicio Health, a UK-based clinically led healthcare company.

The industry has not had this kind of impetus for the 20 years I’ve worked in the space,' says Lincoln International's Carol ...

A MAN has received the world’s first sperm-making stem cell transplant in a groundbreaking experiment to reverse infertility. Jaiwen Hsu, 26, has azoospermia, a condition where no sperm is ...

Crop chem and seed company Syngenta’s interest in ag biologicals has led it to reach a chemistry deal with one of its own ...